Interaction of MTHFR C677T and A1298C, and MTR A2756G gene polymorphisms in breast cancer risk in a population in Northeast Brazil

Anticancer Research

Volumn 32, Issue 11, 2012, Pages 4805-4812

  Barbosa, Rita De Cássia Carvalho ^a   Da Costa, Débora Menezes ^a   Cordeiro, Denise Ellen Francelino ^a   Vieira, Ana Patricia Freitas ^a   Rabenhorst, Silvia Helena Barem ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Breast cancer; Folate metabolism; Single nucleotide polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GENOMIC DNA; HOMOCYSTEINE; METHIONINE SYNTHASE;

ADULT; ARTICLE; BRAZIL; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA METHYLATION; DNA REPAIR; FEMALE; FOLATE METABOLISM; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; AGE FACTORS; BRAZIL; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84872666407     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. National Cancer Institute (NCI). Estimates of the incidence and cancer mortality in Brazil, estimated in 2010 (online). Last accessed: http://www.inca.gov.br/estimativas/2010.
2. Sharp L, Little J, Schofield AC, Pavlidou E, Cotton SC, Miedzybrodzka Z, Baird JOC, Haites NE and Grubb DA: Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett 181: 65-71, 2002.
3. Födinger M, Hörl WH and Sunder-Plassmann G: Molecular biology of 5,10-methylenetetrahydrofolate reductase. Nephrol 13: 20-33, 2000.
4. Choi SW and Mason JB: Folate and carcinogenesis: An integrated scheme. J Nutr 130: 129-132, 2000.
5. Stern LL, Bagley PJ, Rosenberg IH and Selhub J: Conversion of 5-formyltetrahydrofolic acid to 5-methyltetrahydrofolic acid is unimpaired in folateadequate persons homozygous for the C677T mutation in the methylenetetrahydrofolate reductase gene. J Nutr 130: 2238-2242, 2000.
6. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA and van den Heuvel LP: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113, 1995.
7. Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis ER, Eckfeldt JH and Rozen R: The 1298A - >C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 156: 409-415, 2001.
8. Weisberg I, Tran P, Christensen B, Sibani S and Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64: 169-172, 1998.
9. Sohn KJ, Croxford R, Yates Z, Lucock M and Kim YI: Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst 96: 134-144, 2004.
10. Alshatwi AA: Breast cancer risk, dietary intake, and methylenetetrahydrofolate reductase (MTHFR) single nucleotide polymorphisms. Food Chem Toxicol 48(7): 1881-1885, 2012.
11. Campbell IG, Baxter SW, Eccles, DM and Choong DY: Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res 4(6): R14, 2002.
12. Carvalho Barbosa RD, Menezes DC, Freire TF, Sales DC, Alencar VH and Rabenhorst SH: Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent. Mol Biol Rep Apr 39(4): 4899-907, 2012.
13. Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H and Wirfält E: Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev 18(4): 1101-10, 2009.
14. Eroǧlu A and Akar N: Methylenetetrahydrofolate reductase C677T polymorphism in breast cancer risk. Breast Cancer Res Treat 122(3): 897-898, 2010.
15. Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E and Friedman E: Association of the C677T polymorphism in the MTHFR gene with breast and or ovarian cancer risk in Jewish women. Eur J Cancer 36: 2313-2316, 2000.
16. Hosseini M, Houshmand M and Ebrahimi A: MTHFR polymorphisms and breast cancer risk. Arch Med Sci 1: 134-137, 2011.
17. Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh WP and Yu MC: Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis 29(10): 1967-1972, 2008.
18. Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V, Baisch C, Vollmert C, Illig T, Bruning T, Ko Y and Brauch H: One-carbon metabolism and breast cancer risk: No association of, MTR, and TYMS polymorphisms in the GENICA Study from Germany. Cancer Epidemiol Biomarkers Prev 14: 3015-3018, 2005.
19. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Wolf CT, Wascher TC, Paulweber B, Weitzer W and Samonigg H: The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat 81: 169-172, 2003.
20. Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, Han W, Yoo KY, Ahn SH, Choe KJ, Hirvonen A and Noh DY: Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med 36: 116-121, 2004.
21. Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN and Henderson BE: MTHFR polymorphisms, diet, HRT, and breast cancer risk: The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 13: 2071-2077, 2004.
22. Lewis SJ, Harbord RM, Harris R and Smith GD: Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl Cancer Inst 98: 1607-1622, 2006.
23. Ma E, Iwasaki M, Kobayashi M, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R and Tsugane S: Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: A casecontrol study in Japan. Nutr Cancer 61(4): 447-456, 2009.
24. Martin YN, Olson JE, Ingle JN, Vierkant RA, Fredericksen ZS, Pankratz VS, Wu Y, Schaid DJ, Sellers TA and Weinshilboum RM: Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15: 2322-2324, 2006.
25. Mohammad NS, Yedluri R, Addepalli P, Gottumukkala SR, Digumarti RR and Kutala VK: Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer. Mol Cell Biochem 349(1-2): 159-167, 2011.
26. Papandreou CN, Doxani C, Zdoukopoulos N, Vlachostergios PJ, Hatzidaki E, Bakalos G, Ziogas DC, Koufakis T and Zintzaras E: Evidence of association between methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a candidate-gene association study in a south-eastern European population. DNA Cell Biol 31(2): 193-198, 2012.
27. Qiu LX, Zhang J, Li WH, Zhang QL, Yu H, Wang BY, Wang LP, Wang JL, Wang HJ, Liu XJ, Luo ZG and Wu XH: Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility. Mol Biol Rep 38(4): 2295-2299, 2011.
28. Semenza JC, Delfino RJ, Ziogas A and Anton-Culver H: Breast cancer risk and methylenetetrahydrofolate reductase polymorphisms. Breast Cancer Res Treat 77: 217-223, 2003.
29. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, Jin F and Zheng W: MTHFR polymorphisms, dietary folate intake, and breast cancer risk: Results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 13: 190-196, 2004.
30. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, Yamashita T, Iwata H and Tajima K: One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 29(2): 356-362, 2008.
31. Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY and Hu XC: MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Breast Cancer Res Treat 123(2): 549-555, 2010.
32. Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL, Britton JA, Terry MB, Neugut AI and Santella RM: One-carbon metabolism, MTHFR polymorphism and risk of breast cancer. Cancer Res 65: 1606-1614, 2005.
33. Ergul E, Sazci A, Utkan Z and Canturk NE: Polymorphisms in the MTHFR gene are associated with breast cancer. Tumor Biol 24: 286-290, 2003.
34. Försti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, Zientek H, Hemminki K and Kumar R: Single nucleotide polymorphisms in breast cancer. Oncol Rep 11(4): 917-922, 2004.
35. Gao CM, Kazuo T, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, Liu YT, Li SP, Su P, Keitaro M and Toshiro T: MTHFR polymorphisms, dietary folate intake and risks to breast cancer. Zhonghua Yu Fang Yi Xue Za Zhi 43(7): 576-580, 2009.
36. Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, Thun MJ and Calle EE: Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 16: 1140-1147, 2007.
37. Vaǐner AS, Boiarskikh UA, Voronina EN, Selezneva IA, Sinkina TV, Lazarev AF, Petrova VD and Filipenko ML: Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in West Siberian Region of Russia. Mol Biol (Mosk) 44(5): 816-823, 2010.
38. Ziva Cerne J, Stegel V, Gersak K and Novakovic S: Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk. Mol Med Report 4(1): 175-179, 2011.
39. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS, Peng K, Shane B, Evans AE and Whitehead AS: Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17: 298-309, 1999.
40. Sharp L and Little J: Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE review. Am J Epidemiol 159: 423-443, 2004.
41. Lu M, Wang F, Qiu J: Methionine synthase A2756G polymorphism and breast cancer risk: A meta-analysis involving 18,953 subjects. Breast Cancer Res Treat 123(1): 213-217, 2010.
42. Weiner AS, Boyarskikh UA, Voronina EN, Selezneva IA, Sinkina TV, Lazarev AF, Petrova VD and Filipenko ML: Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk. Cancer Epidemiol 36(2): 95-100, 2012.
43. Naushad SM, Pavani A, Digumarti RR, Gottumukkala SR and Kutala VK: Epistatic interactions between loci of one-carbon metabolism modulate susceptibility to breast cancer. Mol Biol Rep 38(8): 4893-4901, 2011.
44. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Jin F and Zheng W: MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15: 586-588, 2006.
45. Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, Wu TY and Sun CA: Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels, and breast cancer susceptibility: A casecontrol study in Taiwan. Carcinogenesis 27: 2295-2300, 2006.
46. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, Kondoh E, Maeda S, Asakura S, Kaba S, Nakamura S, Seto M, Morishima Y and Tajima K: Association between polymorphisms of folate and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97(10): 3205-3209, 2001.
47. Cicek MS, Nock NL, Li L, Conti DV, Casey G and Witte JS: Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev 13(8): 1331-1336, 2004.